Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H20N4 |
InChIKeyQAIMUUJJAJBPCL-UHFFFAOYSA-N |
CAS Registry177355-84-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | ES | 07 Mar 2011 |